Author:
Arendrup M.C.,Meletiadis J.,Zaragoza O.,Jørgensen K.M.,Marcos-Zambrano L.J.,Kanioura L.,Cuenca-Estrella M.,Mouton J.W.,Guinea J.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference19 articles.
1. Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin;Ong;Antimicrob Agents Chemother,2016
2. Structure-activity relationships of a series of echinocandins and the discovery of CD101, a highly stable and soluble echinocandin with distinctive pharmacokinetic properties;James;Antimicrob Agents Chemother,2017
3. Pharmacological basis of CD101 efficacy: exposure shape matters;Lakota;Antimicrob Agents Chemother,2017
4. Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults;Sandison;Antimicrob Agents Chemother,2016
5. Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model;Zhao;Antimicrob Agents Chemother,2017
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献